newsfilter.io
Nov 6, 2026, 9:18 AM ETHealthcare

OneMedNet — Third Quarter 2026 Earnings Summary

ONMDONEMEDNET CORP
Source

Financial Performance

  • Preliminary revenue for the quarter ended September 30, 2026, is approximately $1 million.
  • This represents a 242% increase from the prior quarter ended June 30, 2026.
  • This represents a 465% increase from the prior-year quarter ended September 30, 2025.
  • No specific data on earnings, profit margins, cash flow, deferred revenue, or debt was provided in the press release.

Guidance and Future Outlook

  • Revenue guidance for the fourth quarter of 2026 is approximately $12 million to $14 million.
  • Fourth quarter revenue is pending anticipated acceptance of delivered data by customers.
  • 2026 revenue is weighted to occur at a faster pace in the fourth quarter due to order timing and scaled delivery.
  • Final revenue results for the third quarter are subject to adjustment and will be reported in the Form 10-Q expected by November 16, 2026.

Business Segments and Product Lines

  • The company is scaling its de-identified pipeline and delivery infrastructure to handle regulatory decision-grade, AI-driven Real-World Data (RWD).
  • The platform sources First-Party (Direct-from-Source) multi-modal data directly from healthcare provider partners, avoiding intermediaries or secondary markets.
  • The iRWD™ platform delivers de-identified medical imaging alongside comprehensive clinical records.
  • The sales funnel grew substantially during 2026, with scaled delivery beginning in the third quarter.

Market and Competitive Landscape

  • The company serves life sciences companies, medical device manufacturers, AI developers, and other innovators.
  • The network spans more than 2,300 sites, encompassing over 90 million patient journeys and 270 million studies.
  • Applications supported include drug development, regulatory submissions, and foundational AI model training.

Risks and Challenges

  • Revenue recognition is contingent on customer acceptance of delivered data.
  • Risks include the ability to change the direction of the company, keeping pace with new technology and changing market needs, and the competitive environment.
  • Uncertainties involve the timing of customer acceptance and data delivery.

Management Commentary and Tone

  • Aaron Green, President & CEO, stated that the sales funnel has grown substantially and the company is now delivering on it.
  • Management indicated that the "hardest work" regarding curating, de-identifying, and delivering regulatory-grade multimodal data at scale is substantially complete.
  • The tone reflects confidence in converting sales to revenue and the ability to scale with demand.

Other Key Points

  • The press release serves as a preliminary announcement pending the formal filing of the Quarterly Report on Form 10-Q.
  • No information regarding M&A deals, dividends, or share buybacks was included.
OneMedNet — Third Quarter 2026 Earnings Summary